Stay updated on Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial

Sign up to get notified when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Locations section reorganized to list study sites by state under a single Locations heading (Florida, Massachusetts, New York, Tennessee, Texas, Virginia), replacing the former per-state 'X Locations' subsections. This clarifies where the trial is conducted and makes site information more accessible to potential participants.
    Difference
    0.6%
    Check dated 2025-12-22T22:55:44.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now shows a new revision label 'Revision: v3.3.2' and the previous 'Revision: v3.3.1' label appears to have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T15:48:00.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Minor revision update from v3.2.0 to v3.3.1 with no user-facing content changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T12:51:50.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Removal of the government funding status banner; core study details, eligibility criteria, and locations remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T06:24:33.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    The screenshots show the same Study Details page with no substantive changes to core study information (title, conditions, endpoints, eligibility, enrollment, locations); only visual layout differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:05:51.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Major update: system notice about funding/operating status and a version bump to v3.2.0 (replacing v3.1.0).
    Difference
    3%
    Check dated 2025-10-05T09:26:21.000Z thumbnail image

Stay in the know with updates to Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.